Family Medicine Doctors in Deer Park, TX Accepting Medicare

7 Family Medicine doctors found. Showing 1 - 7

Dr. Derrick Leon Cameron, M.D., MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 5900 Highway 225, Deer Park, TX 77536 Phone: 713-246-6303    Fax: 713-246-7811

Jerry Michael Mcshane, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 321 W. San Augustine St, Deer Park, TX 77536 Phone: 281-476-4616

Donald R Metz, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2910 Center St, Deer Park, TX 77536 Phone: 281-479-5941    Fax: 281-542-1861

Andrew Sparks Metz, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2910 Center St., Deer Park, TX 77536 Phone: 281-479-5941    Fax: 281-479-7056

Natalia Ivanova, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3430 Center St, Deer Park, TX 77536 Phone: 832-548-5000

Melanie Johnson, NP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 2910 Center St, Deer Park, TX 77536 Phone: 281-479-5941

Dr. Judith Martin Cadore, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 125 E 8th St, Deer Park, TX 77536 Phone: 281-930-8555    Fax: 281-930-9870

News Archive

Food scientists develop rapid, reliable technique to ensure fruit and vegetable juices adhere to quality standards

Increasingly, consumer products, especially food and beverage products, are being scrutinized for better quality.

New gonorrhea strain resistant to all antibiotics isolated in Japanese woman

A new strain of the sexually transmitted disease gonorrhea that is resistant to all known antibiotic treatments has been isolated from a female sex worker in Japan, according to Magnus Unemo of the Swedish Reference Laboratory for Pathogenic Neisseria, Reuters reports. Unemo is set to present his findings at a conference of the International Society for Sexually Transmitted Disease Research in Quebec on Monday.

CytRx granted U.S. Patent for bafetinib

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the granting by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent 7,728,131 for oncology drug candidate bafetinib, encompassing claims related to bafetinib's pharmaceutical compound and composition in all indications, as well as for use in methods for treating acute and chronic myelogenous leukemia and acute lymphoblastic leukemia.

Disrupted biological clock can contribute to onset of diseases, USC study shows

USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

Read more Medical News

› Verified 7 days ago